We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines.
- Authors
De Gruijl, Tanja D.; van den Eertwegh, Alfons J. M.; Pinedo, Herbert M.; Scheper, Rik J.
- Abstract
The field of tumor vaccination is currently undergoing a shift in focus, from individualized tailor-made vaccines to more generally applicable vaccine formulations. Although primarily predicated by financial and logistic considerations, stemming from a growing awareness that clinical development for wide-scale application can only be achieved through backing from major pharmaceutical companies, these new approaches are also supported by a growing knowledge of the intricacies and minutiae of antigen presentation and effector T-cell activation. Here, the development of whole-cell tumor and dendritic cell (DC)-based vaccines from an individualized autologous set-up to a more widely applicable allogeneic approach will be discussed as reflected by translational studies carried out over the past two decades at our laboratories and clinics in the vrije universiteit medical center (VUmc) in Amsterdam, The Netherlands.
- Subjects
AMSTERDAM (Netherlands); NETHERLANDS; VACCINATION; CELL tumors; DENDRITIC cells; COLON cancer; CANCER vaccines; CANCER cells; THERAPEUTICS
- Publication
Cancer Immunology, Immunotherapy, 2008, Vol 57, Issue 10, p1569
- ISSN
0340-7004
- Publication type
Article
- DOI
10.1007/s00262-008-0536-z